Endogenous and exogenous hormone exposure and the risk of meningioma in men.

OBJECT Meningioma is a disease with considerable morbidity and is more commonly diagnosed in females than in males. Hormonally related risk factors have long been postulated to be associated with meningioma risk, but no examination of these factors has been undertaken in males. METHODS Subjects were male patients with intracranial meningioma (n = 456), ranging in age from 20 to 79 years, who were diagnosed among residents of the states of Connecticut, Massachusetts, and North Carolina, the San Francisco Bay Area, and 8 counties in Texas and matched controls (n = 452). Multivariate logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for the association between hormonal factors and meningioma risk in men. RESULTS Use of soy and tofu products was inversely associated with meningioma risk (OR 0.50 [95% CI 0.37-0.68]). Increased body mass index (BMI) appears to be associated with an approximately 2-fold increased risk of developing meningioma in men. No other single hormone-related exposure was found to be associated with meningioma risk, although the prevalence of exposure to factors such as orchiectomy and vasectomy was very low. CONCLUSIONS Estrogen-like exogenous exposures, such as soy and tofu, may be associated with reduced risk of meningioma in men. Endogenous estrogen-associated factors such as high BMI may increase risk. Examination of other exposures related to these factors may lead to better understanding of mechanisms and potentially to intervention.

[1]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[2]  M. Wrensch,et al.  Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. , 2013, Journal of neurosurgery.

[3]  C. Hildebolt,et al.  Dental x‐rays and risk of meningioma , 2013, Cancer.

[4]  M. Wrensch,et al.  Cigarette Smoking and Risk of Meningioma: The Effect of Gender , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[5]  N. Hansen,et al.  Soy Isoflavone Supplementation for Breast Cancer Risk Reduction: A Randomized Phase II Trial , 2012, Cancer Prevention Research.

[6]  C. Kruchko,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.

[7]  M. Wrensch,et al.  Family and personal medical history and risk of meningioma. , 2011, Journal of neurosurgery.

[8]  Herbert Yu,et al.  Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls , 2011, International journal of cancer.

[9]  Mi-Kyung Sung,et al.  Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status , 2010, European Journal of Clinical Nutrition.

[10]  X. Shu,et al.  Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. , 2009, The American journal of clinical nutrition.

[11]  Jae-Hyoung Cho,et al.  Mobile communication using a mobile phone with a glucometer for glucose control in Type 2 patients with diabetes: as effective as an Internet-based glucose monitoring system , 2009, Journal of telemedicine and telecare.

[12]  J. Crook,et al.  Is there an association between meningioma and hormone replacement therapy? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Pike,et al.  Epidemiology of soy exposures and breast cancer risk , 2008, British Journal of Cancer.

[14]  P. Black,et al.  Exogenous hormone use and meningioma risk , 2007, Cancer.

[15]  B. Trock,et al.  Meta-analysis of soy intake and breast cancer risk. , 2006, Journal of the National Cancer Institute.

[16]  P. Black,et al.  Expression of Estrogen Receptors Alpha and Beta in Human Meningiomas , 1999, Journal of Neuro-Oncology.

[17]  S. Harrap,et al.  Androgenetic alopecia: pathogenesis and potential for therapy , 2002, Expert Reviews in Molecular Medicine.

[18]  E. Hedley‐Whyte,et al.  Progesterone and estrogen receptors in meningiomas: prognostic considerations. , 1997, Journal of neurosurgery.

[19]  E. Wilson,et al.  Androgen receptor expression in meningiomas. , 1995, Journal of neurosurgery.

[20]  O. Norwood,et al.  Male Pattern Baldness: classification and Incidence , 1975, Southern medical journal.